This is a demo store. No orders will be fulfilled.

Navoximod - 98%, high purity , CAS No.1402837-78-8

    Grade & Purity:
  • ≥98%
In stock
Item Number
N414294
Grouped product items
SKU Size
Availability
Price Qty
N414294-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$118.90
N414294-5mg
5mg
3
$414.90
N414294-10mg
10mg
3
$622.90
N414294-25mg
25mg
2
$806.90
N414294-50mg
50mg
2
$989.90

IDO/TDO Inhibitors

Basic Description

Synonyms NLG-919 | NLG-919 Navoximod | US10233190, Example 1484 | F85292 | (1R,4r)-4-((R)-2-((S)-6-fluoro-5H-imidazo[5,1- a]isoindol-5-yl)-1-hydroxyethyl)cyclohexanol | Navoximod | Navoximod;GDC-0919;IDO-IN-7;NLG-1488 | NAVOXIMOD [INN] | NLG-?919 | UNII-926SHL95NC
Specifications & Purity ≥98%
Biochemical and Physiological Mechanisms Navoximod (GDC-0919, NLG-919) is a potent inhibitor of IDO (indoleamine-(2,3)-dioxygenase) pathway with Ki of 7 nM and EC50 of 75 nM.
Storage Temp Store at -20°C,Argon charged
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Product Description

Information

Navoximod Navoximod (GDC-0919, NLG-919) is a potent inhibitor of IDO (indoleamine-(2,3)-dioxygenase) pathway with Ki of 7 nM and EC50 of 75 nM.


Targets

IDO (Cell-free assay); IDO (Cell-free assay) 7 nM(Ki); 75 nM(EC50)


In vitro

NLG919 potently blocks IDO-induced T-cell suppression and restored robust T-cell responses with ED50 of 80 nM. Similarly, using IDO-expressing mouse DCs from tumor-draining lymph nodes, NLG919 abrogated IDO-induced suppression of antigen-specific T cells (OT-I) with ED50 of 120 nM.\xa0NLG919 increases the cytotoxic activity of paclitaxel toward B16-F10 cells in the presence of pretreatment with interferon (IFN)-γ in vitro.


In vivo

In mice, a single oral administration of NLG919 reduces the concentration of plasma and tissue Kyn by ~ 50%. In mice bearing B16F10 tumors, NLG919 markedly enhances the antitumor responses of naive, resting pmel-1 cells to vaccination with cognate hgp100 peptide plus CpG-1826 in IFA.Immune competent mice are injected orthotopically with genetically engineered murine glioma cells and treated with GDC-0919 alone or combined with RT. GDC-0919 demonstrates potent inhibition of this node and effectively crosses the blood brain barrier. Although GDC-0919 as a single agent does not demonstrate anti-tumor activity, it has a strong potential for enhancing RT response in glioblastoma, which is further augmented with a hypofractionated regimen.


Cell Research(from reference)

Cell lines:the murine melanoma cell line B16-F10 

Concentrations:100\u2009nM 

Incubation Time:12\u2009h, 24\u2009h, 48\u2009h, 72\u2009h 

Taxonomic Classification

Taxonomy Tree

Kingdom Organic compounds
Superclass Organoheterocyclic compounds
Class Isoindoles and derivatives
Subclass Isoindoles
Intermediate Tree Nodes Not available
Direct Parent Isoindoles
Alternative Parents Cyclohexanols  N-substituted imidazoles  Benzenoids  Aryl fluorides  Heteroaromatic compounds  Cyclic alcohols and derivatives  Azacyclic compounds  Organopnictogen compounds  Organonitrogen compounds  Organofluorides  Hydrocarbon derivatives  
Molecular Framework Aromatic heteropolycyclic compounds
Substituents Isoindole - Cyclohexanol - Benzenoid - N-substituted imidazole - Aryl halide - Aryl fluoride - Heteroaromatic compound - Imidazole - Cyclic alcohol - Azole - Secondary alcohol - Azacycle - Organic nitrogen compound - Organic oxygen compound - Organopnictogen compound - Hydrocarbon derivative - Organooxygen compound - Organonitrogen compound - Organofluoride - Organohalogen compound - Alcohol - Aromatic heteropolycyclic compound
Description This compound belongs to the class of organic compounds known as isoindoles. These are heteropolycyclic compounds with a structure containing isoindole, a benzo-fused pyrrole.
External Descriptors Not available

Product Properties

ALogP 2.224
hba_count 1
HBD Count 2
Rotatable Bond 3

Names and Identifiers

Pubchem Sid 504771996
Pubchem Sid Url https://pubchem.ncbi.nlm.nih.gov/substance/504771996
IUPAC Name 4-[(1R)-2-[(5S)-6-fluoro-5H-imidazo[5,1-a]isoindol-5-yl]-1-hydroxyethyl]cyclohexan-1-ol
INCHI InChI=1S/C18H21FN2O2/c19-14-3-1-2-13-16-9-20-10-21(16)15(18(13)14)8-17(23)11-4-6-12(22)7-5-11/h1-3,9-12,15,17,22-23H,4-8H2/t11?,12?,15-,17+/m0/s1
InChIKey YGACXVRLDHEXKY-LHPNLFKDSA-N
Smiles C1CC(CCC1C(CC2C3=C(C=CC=C3F)C4=CN=CN24)O)O
Isomeric SMILES C1CC(CCC1[C@@H](C[C@H]2C3=C(C=CC=C3F)C4=CN=CN24)O)O
Molecular Weight 316.37
Reaxy-Rn 30199924
Reaxys-RN_link_address https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=30199924&ln=

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

5 results found

Lot Number Certificate Type Date Item
I2205237 Certificate of Analysis Jun 09, 2025 N414294
I2205311 Certificate of Analysis Jun 09, 2025 N414294
I2205312 Certificate of Analysis Jun 09, 2025 N414294
I2205310 Certificate of Analysis Jun 09, 2025 N414294
L2420228 Certificate of Analysis Jun 15, 2022 N414294

Chemical and Physical Properties

Solubility Solubility (25°C) In vitro DMSO: 63 mg/mL (199.13 mM); Ethanol: 63 mg/mL (199.13 mM); Water: Insoluble;
DMSO(mg / mL) Max Solubility 63
DMSO(mM) Max Solubility 199.133925467016
Water(mg / mL) Max Solubility <1
Molecular Weight 316.400 g/mol
XLogP3 2.100
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 4
Rotatable Bond Count 3
Exact Mass 316.159 Da
Monoisotopic Mass 316.159 Da
Topological Polar Surface Area 58.300 Ų
Heavy Atom Count 23
Formal Charge 0
Complexity 416.000
Isotope Atom Count 0
Defined Atom Stereocenter Count 2
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
The total count of all stereochemical bonds 0
Covalently-Bonded Unit Count 1

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.